{"id":28,"date":"2026-08-17T12:53:22","date_gmt":"2026-08-17T12:53:22","guid":{"rendered":"https:\/\/peptide-doc.com\/learn\/semax\/"},"modified":"2026-09-02T19:41:50","modified_gmt":"2026-09-02T19:41:50","slug":"semax","status":"publish","type":"learn_article","link":"https:\/\/peptide-doc.com\/de\/learn\/semax\/","title":{"rendered":"Semax"},"content":{"rendered":"
\nMETA-TITLE:<\/strong> [TODO: Semax \u2014 Nootropic Peptide Research Profile | Brand]
\nMETA-DESC:<\/strong> [TODO: Semax research overview \u2014 ACTH(4-10) analog, BDNF upregulation, neuroprotection, cognitive research.]\n<\/div>\n

[TODO]<\/span> Hook \u2014 Semax as a Russian-developed nootropic peptide, prescribed in Russia\/Ukraine since 1990s, BDNF upregulation, unique melanocortin pathway<\/p>\n

[IMAGE: Semax molecular structure \u2014 heptapeptide ACTH(4-10) + Pro-Gly-Pro]<\/div>\n

What is Semax?<\/h2>\n
    \n
  • [TODO]<\/span> Full name \u2014 Semax, Met-Glu-His-Phe-Pro-Gly-Pro (ACTH 4-10 analog + PGP)<\/li>\n
  • [TODO]<\/span> Origin \u2014 developed at the Institute of Molecular Genetics, Russian Academy of Sciences<\/li>\n
  • [TODO]<\/span> Classification \u2014 synthetic melanocortin derivative, nootropic peptide<\/li>\n
  • [TODO]<\/span> Approved use \u2014 Russia (stroke recovery, cognitive enhancement, optic nerve disease)<\/li>\n
  • [TODO]<\/span> Administration \u2014 intranasal (primary), subcutaneous<\/li>\n<\/ul>\n

    Mechanism of Action<\/h2>\n
    [IMAGE: Semax mechanism diagram \u2014 BDNF pathway, melanocortin receptors, dopaminergic\/serotonergic modulation]<\/div>\n
      \n
    • [TODO]<\/span> BDNF upregulation \u2014 increases Brain-Derived Neurotrophic Factor expression<\/li>\n
    • [TODO]<\/span> Melanocortin system \u2014 MC3\/MC4 receptor interaction (without ACTH hormonal effects)<\/li>\n
    • [TODO]<\/span> Dopaminergic \u2014 modulates dopamine and serotonin turnover<\/li>\n
    • [TODO]<\/span> Neuroprotection \u2014 anti-oxidative, anti-inflammatory in CNS<\/li>\n
    • [TODO]<\/span> NGF \/ TrkB \u2014 neurotrophic factor signaling enhancement<\/li>\n<\/ul>\n

      Research Highlights<\/h2>\n
        \n
      • [TODO]<\/span> Stroke \u2014 accelerated cognitive recovery in ischemic stroke patients (Russian trials)<\/li>\n
      • [TODO]<\/span> Memory \u2014 improved attention, memory consolidation in animal and human studies<\/li>\n
      • [TODO]<\/span> ADHD \u2014 Russian pediatric studies showing attention improvement<\/li>\n
      • [TODO]<\/span> Optic nerve \u2014 neuroprotective in optic nerve atrophy (clinical use in Russia)<\/li>\n
      • [TODO]<\/span> Gene expression \u2014 modulates 24 genes related to immune and vascular function<\/li>\n<\/ul>\n

        Dosing Protocols (Research Context)<\/h2>\n
          \n
        • [TODO]<\/span> Intranasal \u2014 200-600mcg\/day (1-2 drops per nostril, 2-3x daily)<\/li>\n
        • [TODO]<\/span> Subcutaneous \u2014 100-500mcg\/day<\/li>\n
        • [TODO]<\/span> N-Acetyl Semax variant \u2014 enhanced stability, higher potency per mcg<\/li>\n
        • [TODO]<\/span> Duration \u2014 10-14 day cycles, can repeat after washout<\/li>\n<\/ul>\n

          Safety & Considerations<\/h2>\n
            \n
          • [TODO]<\/span> Excellent safety \u2014 decades of clinical use in Russia, no major adverse events<\/li>\n
          • [TODO]<\/span> No hormonal ACTH effects \u2014 does not affect cortisol, adrenal function<\/li>\n
          • [TODO]<\/span> Mild effects \u2014 occasional nasal irritation (intranasal), headache<\/li>\n
          • [TODO]<\/span> Western data gap \u2014 limited peer-reviewed English-language clinical data<\/li>\n<\/ul>\n

            Frequently Asked Questions<\/h2>\n
            [FAQ: How does Semax differ from Selank?]<\/div>\n
            [FAQ: Is intranasal or subcutaneous administration more effective?]<\/div>\n
            [FAQ: What is N-Acetyl Semax and how does it differ?]<\/div>\n
            [FAQ: Can Semax affect cortisol levels like ACTH?]<\/div>\n

            Related Products<\/h2>\n

            [TODO]<\/span> Link to Semax product page + Cognitive category<\/p>\n","protected":false},"excerpt":{"rendered":"

            [META-DESC TODO: Semax research profile \u2014 ACTH(4-10) analog, neuroprotection, BDNF, cognitive enhancement.]<\/p>\n","protected":false},"featured_media":0,"template":"","learn_category":[6],"class_list":["post-28","learn_article","type-learn_article","status-publish","hentry","learn_category-cognitive"],"_links":{"self":[{"href":"https:\/\/peptide-doc.com\/de\/wp-json\/wp\/v2\/learn_article\/28","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/peptide-doc.com\/de\/wp-json\/wp\/v2\/learn_article"}],"about":[{"href":"https:\/\/peptide-doc.com\/de\/wp-json\/wp\/v2\/types\/learn_article"}],"version-history":[{"count":1,"href":"https:\/\/peptide-doc.com\/de\/wp-json\/wp\/v2\/learn_article\/28\/revisions"}],"predecessor-version":[{"id":51,"href":"https:\/\/peptide-doc.com\/de\/wp-json\/wp\/v2\/learn_article\/28\/revisions\/51"}],"wp:attachment":[{"href":"https:\/\/peptide-doc.com\/de\/wp-json\/wp\/v2\/media?parent=28"}],"wp:term":[{"taxonomy":"learn_category","embeddable":true,"href":"https:\/\/peptide-doc.com\/de\/wp-json\/wp\/v2\/learn_category?post=28"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}